Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where T. Tran is active.

Publication


Featured researches published by T. Tran.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013

Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer†

L. Matthew Scala; Kenneth Hu; Mark L. Urken; Adam Jacobson; Mark S. Persky; T. Tran; Mark L. Smith; Stimson Schantz; Louis B. Harrison

The purpose of this article was to present the Beth Israel Medical Center experience using high‐dose‐rate intraoperative radiotherapy (HDR‐IORT) in the management of recurrent head and neck cancer.


Oral Oncology | 2017

Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck

Kenneth S. Hu; W.F. Mourad; M.E. Gamez; W. Lin; Adam Saul Jacobson; Mark S. Persky; Mark L. Urken; B. Culliney; Z. Li; T. Tran; Stimson P. Schantz; Juskaran Chadha; Louis B. Harrison

PURPOSE Squamous cell carcinoma of unknown primary (SCCHNUP) is commonly treated with comprehensive radiation to the laryngopharynx and bilateral necks. In 1998, we established a departmental policy to treat SCCHNUP with radiation directed to the oropharynx and bilateral neck. METHODS From 1998-2011, 60 patients were treated - N1: 18%, N2: 75% and N3: 7%. 82% underwent neck dissection. 55% received IMRT and 62% underwent concurrent chemoradiotherapy. RESULTS At median follow-up of 54months, 5 patients failed regionally and 4 emerged with a primary (tongue base, hypopharynx and thoracic esophagus). Five-year rates of regional control, primary emergence, distant metastasis, disease-free survival and overall survival were 90%, 10%, 20%, 72% and 79%, respectively. The 5year rate of primary emergence in a non-oropharynx site was 3%. CONCLUSION This is the first demonstration that an oropharynx-directed approach yields low rates of primary emergence in SCCHNUP with excellent oncologic outcomes.


Otolaryngology-Head and Neck Surgery | 2007

Early experience with minimally invasive esophagectomy in head and neck surgical patients

Luc G. Morris; T. Tran; Mark D. DeLacure

Background Minimally invasive esophagectomy (MIE) via thoracoscopy and laparoscopy have reduced the morbidity and mortality of total esophagectomy at experienced centers. MIE has not been evaluated in combination with major head and neck surgery, or in the otolaryngology literature. Methods Case series of 11 consecutive patients undergoing either open or MIE with an ablative neck procedure. Results Comparing 4 MIEs and 7 open operations, similar operative time, blood loss, and ICU and hospital length of stay were observed. There was one mortality in the open group. A 100% rate of major complications was observed in the MIE group. Conclusion Our multidisciplinary team was unable to achieve improved outcomes in a series of head and neck surgical patients undergoing MIE. This result may represent an early stage of the learning curve for MIE, but may also be attributed to the escalated surgical requirements of head and neck patients.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017

Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization

Kenneth S. Hu; W.F. Mourad; M.E. Gamez; Joseph Safdieh; W. Lin; Adam Saul Jacobson; Mark S. Persky; Mark L. Urken; B. Culliney; Z. Li; T. Tran; Stimson P. Schantz; Juskaran Chadha; Louis B. Harrison

Unilateral radiotherapy (RT) of oropharyngeal carcinomas is accepted for patients with lateralized primary and low‐volume nodal disease. Utilizing prospectively defined criteria of laterality and staging positron emission tomography (PET)/CT, we studied outcomes in patients with advanced‐stage oropharyngeal cancer undergoing unilateral RT.


Otolaryngologic Clinics of North America | 2018

Acquired Vascular Tumors of the Head and Neck

Mark S. Persky; T. Tran

Vascular neoplasms of the head and neck present with a wide spectrum of signs and symptoms. Diagnosis requires a high index of suspicion and is usually made after tumors are large enough to be visually apparent or cause symptoms. This article discusses the most common acquired benign and malignant vascular tumors, with an emphasis on their evaluation and treatment.


Journal of Clinical Oncology | 2011

High dose rate intraoperative radiation therapy for recurrent head and neck cancer: The importance of in-field control on survival.

Louis B. Harrison; W.F. Mourad; M. Perksy; Mark L. Urken; Adam Jacobson; B. Culliney; T. Tran; Stimson P. Schantz; P. Costantino; Kenneth Hu


International Journal of Radiation Oncology Biology Physics | 2018

Functional Swallowing Outcomes Using FEES Evaluation After Swallowing-Sparing IMRT in Unilateral Versus Bilateral Neck Radiation

M. Tam; J. Mojica; N.S. Kim; D. No; Z. Li; T. Tran; M. DeLacure; B. Givi; A. Jacobson; M. Persky; Kenneth S. Hu


International Journal of Radiation Oncology Biology Physics | 2018

Utilization of Immunotherapy in Head and Neck Cancers Pre-Food and Drug Administration Approval of Immune Checkpoint Inhibitors

S.P.P. Wu; M. Tam; N.K. Gerber; Z. Li; B. Schmidt; M. Persky; N.J. Sanfilippo; T. Tran; A. Jacobson; M. DeLacure; Kenneth S. Hu; D.P. Schreiber; Babak Givi


Journal of Clinical Oncology | 2017

PEG status and outcomes in head and neck cancer patients treated with chemoradiotherapy.

Cathy L. Lazarus; Hasan Husaini; Kenneth Hu; B. Culliney; Zujun Li; Mark L. Urken; Adam Jacobson; Daniel Buchbinder; Mark S. Persky; T. Tran; Michael Pitman; C. Concert; Daisy Maria Palacios; Bridget Bennett; Mahesh Kumar; Robin Metcalfe-Klaw; Louis B. Harrison


Journal of Clinical Oncology | 2017

Comparison of patient performance between PEG/no PEG placement in head and neck cancer patients during chemoradiotherapy treatment.

Robin Metcalfe-Klaw; Hasan Husaini; Cathy L. Lazarus; Louis B. Harrison; B. Culliney; Zujun Li; Mark L. Urken; Adam Jacobson; Daniel Buchbinder; Mark S. Persky; T. Tran; Michael Pitman; C. Concert; Daisy Maria Palacios; Bridget Bennett; Mahesh Kumar; Kenneth Hu

Collaboration


Dive into the T. Tran's collaboration.

Top Co-Authors

Avatar

Louis B. Harrison

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mark L. Urken

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. Culliney

Beth Israel Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kenneth Hu

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stimson P. Schantz

New York Eye and Ear Infirmary

View shared research outputs
Top Co-Authors

Avatar

W.F. Mourad

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar

Z. Li

New York University

View shared research outputs
Researchain Logo
Decentralizing Knowledge